Literature DB >> 19590874

Adherence to treatment guidelines in two primary care populations with gout.

Geoffrey C Wall1, Carrie F Koenigsfeld, Karly A Hegge, Michelle M Bottenberg.   

Abstract

Published guidelines for the treatment of gout aim to improve the evidenced-based management of this disorder. Unfortunately, several studies suggest that these guidelines are not routinely followed in clinical practice. Limited data exist comparing different groups of primary care providers regarding compliance with published gout guidelines. We conducted a retrospective study comparing two different general internal medicine (IM) practices and evaluated compliance with these guidelines. All patients with a billing code for gout seen in two large IM clinics (Clinic A, an inner-city urban clinic, and Clinic B, a suburban clinic) between January 2004 and December 2007 were selected for chart review. Patients referred to a rheumatologist for management of gout were excluded. The care received by these patients for gout was compared to recommendations from published guidelines, with the primary outcome assessing the percentage of patients who received at least yearly monitoring of serum uric acid (SUA) levels. In both clinics, yearly monitoring of SUA levels occurred in approximately one quarter of the patients with gout (Clinic A 27.5% vs. Clinic B 28.9%, P = 0.87). Compared to SUA, renal function was monitored more frequently in each of the groups. Listed indications for antihyperuricemic therapy were similar between groups, although gouty flares were reported more frequently in clinic B (P = 0.005). In this retrospective review of gout management in two IM clinics, general care for patients with this condition did not differ significantly. However, overall compliance with recommendations from published guidelines was low.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590874     DOI: 10.1007/s00296-009-1056-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  How is gout managed in primary care? A review of current practice and proposed guidelines.

Authors:  B Pal; M Foxall; T Dysart; F Carey; M Whittaker
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

2.  Epidemiology of gout: is the incidence rising?

Authors:  Emvalee Arromdee; Clement J Michet; Cynthia S Crowson; W Michael O'Fallon; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2002-11       Impact factor: 4.666

Review 3.  Clinical practice. Gout.

Authors:  Robert A Terkeltaub
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

Review 4.  Quality of care indicators for gout management.

Authors:  Ted R Mikuls; Catherine H MacLean; Jason Olivieri; Fausto Patino; Jeroan J Allison; John T Farrar; Warren B Bilker; Kenneth G Saag
Journal:  Arthritis Rheum       Date:  2004-03

5.  Gout medication treatment patterns and adherence to standards of care from a managed care perspective.

Authors:  Chaitanya A Sarawate; Kathleen K Brewer; Wenya Yang; Pankaj A Patel; H Ralph Schumacher; Kenneth G Saag; Alan W Bakst
Journal:  Mayo Clin Proc       Date:  2006-07       Impact factor: 7.616

Review 6.  EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; E Pascual; T Bardin; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

Review 7.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

8.  Academic detailing to improve antihypertensive prescribing patterns.

Authors:  David Siegel; Julio Lopez; Joy Meier; Mary K Goldstein; Samuel Lee; Bradley J Brazill; Mazen S Matalka
Journal:  Am J Hypertens       Date:  2003-06       Impact factor: 2.689

9.  Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).

Authors:  T R Mikuls; J T Farrar; W B Bilker; S Fernandes; K G Saag
Journal:  Rheumatology (Oxford)       Date:  2005-05-03       Impact factor: 7.580

10.  Gout in the elderly--a population health study.

Authors:  John G Hanly; Chris Skedgel; Ingrid Sketris; Charmaine Cooke; Tina Linehan; Kara Thompson; Sander Veldhuyzen van Zanten
Journal:  J Rheumatol       Date:  2009-03-13       Impact factor: 4.666

View more
  13 in total

Review 1.  Tophaceous gout in the elderly: a clinical case review.

Authors:  Francesco Bolzetta; Nicola Veronese; Enzo Manzato; Giuseppe Sergi
Journal:  Clin Rheumatol       Date:  2012-02-25       Impact factor: 2.980

2.  Gout treatment: survey of Brazilian rheumatology residents.

Authors:  Rodrigo Balbino Chaves Amorim; Ana Beatriz Vargas-Santos; Leticia Rocha Pereira; Evandro Silva Freire Coutinho; Geraldo da Rocha Castelar-Pinheiro
Journal:  Clin Rheumatol       Date:  2017-01-19       Impact factor: 2.980

Review 3.  Update on gout: new therapeutic strategies and options.

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

4.  Adherence to uric acid treatment guidelines in a rheumatology clinic.

Authors:  Richard Conway; Robert J Coughlan; John J Carey
Journal:  Clin Rheumatol       Date:  2012-09-05       Impact factor: 2.980

5.  Gout in primary care: Can we improve patient outcomes?

Authors:  Jacqueline Callear; Georgina Blakey; Alexandra Callear; Linda Sloan
Journal:  BMJ Qual Improv Rep       Date:  2017-04-25

Review 6.  Treatment approaches and adherence to urate-lowering therapy for patients with gout.

Authors:  Thanda Aung; Gihyun Myung; John D FitzGerald
Journal:  Patient Prefer Adherence       Date:  2017-04-19       Impact factor: 2.711

7.  Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.

Authors:  Carly A Janssen; Tim L Th A Jansen; Martijn A H Oude Voshaar; Harald E Vonkeman; Mart A F J van de Laar
Journal:  Rheumatol Int       Date:  2017-07-26       Impact factor: 2.631

8.  Mapping patients' experiences from initial symptoms to gout diagnosis: a qualitative exploration.

Authors:  Jennifer Liddle; Edward Roddy; Christian D Mallen; Samantha L Hider; Suman Prinjha; Sue Ziebland; Jane C Richardson
Journal:  BMJ Open       Date:  2015-09-14       Impact factor: 2.692

9.  Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice.

Authors:  Elizabeth Cottrell; Valerie Crabtree; John J Edwards; Edward Roddy
Journal:  BMC Fam Pract       Date:  2013-11-14       Impact factor: 2.497

10.  A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.

Authors:  Jane C Richardson; Jennifer Liddle; Christian D Mallen; Edward Roddy; Samantha Hider; Suman Prinjha; Sue Ziebland
Journal:  BMC Musculoskelet Disord       Date:  2016-06-06       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.